Try the new FT.com

    Search for Johnson & Johnson Co Inc and
    1. March 9, 2017

      Johnson & Johnson to cut 400 jobs in Scotland

      Johnson & Johnson plans to close a Scottish surgical suture factory with the loss of about 400 jobs as part of a global...

    2. March 7, 2017

      Trump’s pledge on drug pricing squeezes US pharma stocks

      Donald Trump’s latest pledge to drive down drug prices squeezed pharmaceutical stocks on Tuesday, pushing the sector’s...

    Special Reports

    1. Health at Work

      Policymakers and employers are becoming more sensitive to workplace health. As researc...
    2. Innovation in Healthcare

      When a top Formula One team is using pit stop data-gathering technology to help a drug...
    Search more Special Reports on this topic.

    1. March 7, 2017

      J&J’s legal costs surge in wave of product lawsuits

      Johnson & Johnson’s legal costs jumped last year after a surge in the number of people suing the world’s largest...

    2. February 13, 2017

      GSK claims new HIV combination therapy will be ‘less harmful’

      GlaxoSmithKline claimed that its new HIV treatment would be “less harmful and less hassle” than current therapies, as...

    3. February 2, 2017

      What business thinks of Donald Trump

      These are emotional days in the US c-suite. From fear to excitement, from optimism to outrage: Donald Trump provokes...

    4. January 27, 2017

      Week in Review: January 28

      A round up of some of the week’s most significant corporate events and news stories. $100bn spells success for Alphabet...

    5. January 26, 2017

      J&J boss’s long quest ends with $30bn Actelion deal

      Johnson & Johnson’s $30bn acquisition of Actelion, the Swiss biotech group, caps a years-long quest to find a deal of...

    6. January 26, 2017

      Johnson & Johnson to buy Swiss biotech company Actelion for $30bn

      Johnson & Johnson unveiled the biggest deal in its 130-year history on Thursday as the world’s largest healthcare...

    7. January 26, 2017

      J&J/Actelion: high pressure sale

      Pricey place, Switzerland. Those flashy watches cost thousands, local pharma companies even more. Johnson & Johnson has...

    8. Fast FT

      January 26, 2017

      Actelion shares up 21% after takeover announcement

      Shares in Swiss biotech group Actelion jumped 21 per cent on Thursday morning after it agreed to a $30bn takeover by...

    9. Fast FT

      January 26, 2017

      Johnson & Johnson to buy Actelion for $30bn

      Johnson & Johnson has agreed to acquire biotechnology company Actelion for $30bn in a deal that would see the latter’s...

    10. January 24, 2017

      J&J blames strong dollar for disappointing 2017 forecast

      Johnson & Johnson, the world’s largest healthcare company, blamed a stronger dollar as it forecast that 2017 profits...

    11. January 18, 2017

      Drug companies pledge to improve emerging markets cancer care

      More than 20 of the world’s leading drug companies have pledged to work together to treat cancer and other...

    12. January 12, 2017

      Drug stocks tumble as Trump singles out pharma companies

      Donald Trump has rocked the pharmaceutical industry by unexpectedly warning that his government will push for lower...

    13. December 22, 2016

      Actelion/J&J: hypertension tactics

      FOMO, the fear of missing out, drives us to make decisions for the wrong reasons, such as envy. It can also lead to us...

    14. December 21, 2016

      Johnson & Johnson and Actelion disclose ‘exclusive’ deal talks

      Johnson & Johnson has entered exclusive talks over a deal with Actelion, the Swiss biotech group, just a week after...

    15. December 14, 2016

      Sanofi in talks to buy biotech Actelion as J&J bows out

      Sanofi, the French drugmaker, is in talks to buy Actelion, Europe’s largest biotech company, in a deal potentially...

    16. December 14, 2016

      Actelion: PAH, humbug

      Actelion is unusual among pharma makers. This Swiss company produces a profitable drug for a rare disease , and has...

    17. Fast FT

      December 14, 2016

      Johnson & Johnson ends bid for Actelion

      Johnson & Johnson has abruptly ended talks to acquire Actelion, a move that would have allowed it to takeover Europe’s...

    18. December 2, 2016

      J&J ordered to pay $1bn in hip-replacement suit

      A US jury ordered Johnson & Johnson to pay more than $1bn in damages in a case in which six plaintiffs claimed to have...

    19. November 28, 2016

      Actelion weighs complex deal to combine with part of J&J

      Actelion, Europe’s largest biotech company, is considering a complicated deal to combine with part of Johnson &...

    20. November 28, 2016

      Actelion: independent thinking

      As corporate headquarters go, the Actelion Business Center is a statement of intent. Designed by Herzog & de Meuron, it...

    21. November 25, 2016

      J&J confirms talks with Actelion over pharma deal

      Johnson & Johnson, the world’s largest healthcare group, confirmed on Friday it is in preliminary discussions with...

    22. Fast FT

      November 25, 2016

      Actelion confirms approach by J&J

      Europe’s biggest biotech group has confirmed that it has been approached by Johnson & Johnson “about a possible...

    23. Fast FT

      November 25, 2016

      Actelion shares jump after takeover report

      Shares in Actelion jumped as much as 10 per cent this morning after reports Europe’s biggest biotech group may be a...

    24. October 18, 2016

      J&J prepares for drug price war with Pfizer

      Johnson & Johnson set the stage for a price war in one of the most lucrative segments of the pharmaceuticals industry,...

    25. October 11, 2016

      Samsung: the Tylenol test

      More than 30 years afterwards, Johnson & Johnson’s handling of the Tylenol recall remains the key case study on how to...

    26. October 5, 2016

      J&J warns insulin pumps could be hacked

      Johnson & Johnson has warned over 100,000 diabetes patients of a flaw in their insulin pumps, marking the first time...

    27. Fast FT

      September 16, 2016

      J&J buys Abbott Medical for $4.3bn in eye surgery push

      US drugmaker Johnson & Johnson has said it will acquire a subsidiary of Abbott Laboratories for $4.3bn in cash in a...

    28. September 14, 2016

      UK and US: Workplace tale of two healthcare systems

      When Simon Stevens was working in the US, his employer United Healthcare provided incentives which prodded him to lose...

    29. August 3, 2016

      Crisis management at a bitcoin exchange is a sign of immaturity

      Visit Reddit now for a live case study in corporate communication, bitcoin-style. Zane Tackett, director of community...

    30. July 28, 2016

      Shift to organics gives Johnson & Johnson the babycare blues

      When Alexis and Gabe Landes found out they were expecting their first child, they began preparing their apartment on...

    31. Fast FT

      July 19, 2016

      US stocks fluctuate as earnings sway markets

      The latest batch of results from corporate America kept US stocks fluctuating between modest losses and gains on...

    32. Fast FT

      July 19, 2016

      J&J jumps as drug sales power earnings

      Johnson and Johnson published earnings that were ahead of Wall Street expectations after strong sales of new...

    33. June 23, 2016

      The dark side of wealth has a name: ‘illth’

      “Wealth” is an uncomfortably broad term. It can be applied to natural riches (the “common wealth”) and cash earned...

    34. June 9, 2016

      At Work with the FT: Joanna Jensen, founder and CEO, Childs Farm

      Joanna Jensen is having to sell her stables. The former horse breeder who left a career in investment banking says her...

    35. June 5, 2016

      New cancer drugs target deadliest forms of the disease

      Johnson & Johnson, AbbVie and other large pharmaceutical companies on Sunday unveiled research showing that their drugs...

    36. June 2, 2016

      J&J to buy Vogue International for $3.3bn

      Johnson & Johnson agreed to buy Vogue International, maker of hair care and personal products, for $3.3bn, as the US...

    37. Fast FT

      June 2, 2016

      J&J to buy Vogue International for $3.3bn

      US health-care and consumer giant Johnson & Johnson has agreed to buy Vogue International, maker of hair care and...

    38. June 1, 2016

      Cancer doctors face next drug challenge

      More than 30,000 doctors and scientists will gather in Chicago this weekend for the biggest annual meeting of cancer...

    Search for Johnson & Johnson Co Inc and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Rob Armstrong on why $18bn cash pile is a bad acquisition...
      Thu Feb 04 15:13:05 GMT 2016

      Rob Armstrong on why $18bn cash pile is a bad acquisition